Literature DB >> 17845167

A randomized, investigator-blinded, time-ranging study of the comparative efficacy of 0.5% malathion gel versus Ovide Lotion (0.5% malathion) or Nix Crème Rinse (1% permethrin) used as labeled, for the treatment of head lice.

Terri L Meinking1, Maureen Vicaria, Deborah H Eyerdam, Maria Elena Villar, Susan Reyna, German Suarez.   

Abstract

One hundred seventy-two subjects with head lice participated in a five-way, investigator-blinded, parallel-group, active-controlled study comparing 0.5% malathion gel (30, 60, and 90 minutes applications), Ovide Lotion (0.5% malathion), and Nix Crème Rinse (1% permethrin). All subjects were treated on day 1. Participants were reevaluated at day 8 +/- 1 and those with live lice were retreated with the same product, for the same duration as day 1. Cure, defined as the absence of live lice, was evaluated 14 +/- 2 days after the last treatment and 161 subjects completed the study according to the protocol. Compared to Nix, treatment success rates were statistically superior for all malathion gel and Ovide groups. Retreatment rate for Nix was 70%, which was statistically more than the malathion groups. The highest treatment success rates were observed for the 30-minute malathion gel (98% intent-to-treat and 100% per-protocol [PP]) and the 8 to 12 hour Ovide application (97% intent-to-treat and 100% PP). In conclusion, the 30-minute malathion gel, which contains the same ingredients and concentrations as Ovide, provides comparable efficacy, offers increased safety and is more cosmetically acceptable than Ovide.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17845167     DOI: 10.1111/j.1525-1470.2007.00460.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  8 in total

1.  Head louse control by suffocation due to blocking their oxygen uptake.

Authors:  Saleh Al-Quraishy; Fathy Abdel-Ghaffar; Heinz Mehlhorn
Journal:  Parasitol Res       Date:  2015-05-21       Impact factor: 2.289

Review 2.  Head lice.

Authors:  Ian F Burgess
Journal:  BMJ Clin Evid       Date:  2011-05-16

3.  Cutaneous infections and infestations: new therapies.

Authors:  Emily C Keller; Kenneth J Tomecki
Journal:  J Clin Aesthet Dermatol       Date:  2011-12

4.  Ex vivo effectiveness of French over-the-counter products against head lice (Pediculus humanus capitis De Geer, 1778).

Authors:  Catherine Combescot-Lang; Robert H Vander Stichele; Berthine Toubate; Emilie Veirron; Kosta Y Mumcuoglu
Journal:  Parasitol Res       Date:  2015-02-27       Impact factor: 2.289

5.  Head lice treatments and school policies in the US in an era of emerging resistance: a cost-effectiveness analysis.

Authors:  Itzhak Gur; Ronald Schneeweiss
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

Review 6.  Treatment of Pediculosis Capitis.

Authors:  Prashant Verma; Chaitanya Namdeo
Journal:  Indian J Dermatol       Date:  2015 May-Jun       Impact factor: 1.494

7.  Frequency of pyrethroid resistance in human head louse treatment: systematic review and meta-analysis.

Authors:  Jalal Mohammadi; Kourosh Azizi; Hamzeh Alipour; Mohsen Kalantari; Masoumeh Bagheri; Marzieh Shahriari-Namadi; Saeedeh Ebrahimi; Mohammad D Moemenbellah-Fard
Journal:  Parasite       Date:  2021-12-22       Impact factor: 3.000

8.  Expansion of the Knockdown Resistance Frequency Map for Human Head Lice (Phthiraptera: Pediculidae) in the United States Using Quantitative Sequencing.

Authors:  Kyle J Gellatly; Sarah Krim; Daniel J Palenchar; Katie Shepherd; Kyong Sup Yoon; Christopher J Rhodes; Si Hyeock Lee; J Marshall Clark
Journal:  J Med Entomol       Date:  2016-03-31       Impact factor: 2.278

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.